Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
12.21
+1.99 (19.47%)
At close: Aug 28, 2025, 4:00 PM
12.49
+0.28 (2.29%)
After-hours: Aug 28, 2025, 7:59 PM EDT

Neuphoria Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Neuphoria Therapeutics stock has a target of 21, which predicts a 71.99% increase from the current stock price of 12.21.

Price Target: $21 (+71.99%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$21$21$21$21
Change+71.99%+71.99%+71.99%+71.99%

Analyst Ratings

According to 1 stock analyst, the rating for Neuphoria Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25Aug '25
Strong Buy111
Buy000
Hold000
Sell000
Strong Sell000
Total111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong BuyReiterates$21+71.99%Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$8$21
Strong BuyMaintains$8$21+71.99%Feb 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
1.96M
EPS This Year
-11.73
from -0.01
EPS Next Year
-0.70
from -11.73
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2025
Period EndingJun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2025
Revenue
2.07M695.81K4.17M---1.96M
Revenue Growth
-59.99%-66.32%499.60%----
EPS
-0.01-0.01-0.01-0.01-0.01-11.73-0.70
EPS Growth
-------
Forward PE
-------
No. Analysts
-----34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
High2.0M
Avg2.0M
Low1.9M

Revenue Growth

Revenue Growth2025
High-
Avg-
Low-

EPS Forecast

EPS2025
High-0.44
Avg-0.70
Low-0.94

EPS Growth

EPS Growth2025
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.